Our results also suggest that targeting Meis1 in skin tumors could be a powerful strategy for the treatment of skin cancer as well as other epithelial tumors in which Meis1 appears to have an oncogenic role, such as endometrial and ovarian cancers. This evidence concerns the gene MEIS1 and ovarian carcinoma.